Takeda Pharmaceutical Shares Outstanding 2007-2020 | TAK

Takeda Pharmaceutical shares outstanding history from 2007 to 2020. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Takeda Pharmaceutical shares outstanding for the quarter ending March 31, 2020 were 3.132B, a 99.17% increase year-over-year.
  • Takeda Pharmaceutical 2020 shares outstanding were 3.132B, a 61.98% increase from 2019.
  • Takeda Pharmaceutical 2019 shares outstanding were 1.934B, a 22.9% increase from 2018.
  • Takeda Pharmaceutical 2018 shares outstanding were 1.573B, a 0.1% increase from 2017.
Takeda Pharmaceutical Annual Shares Outstanding
(Millions of Shares)
2020 3,132
2019 1,934
2018 1,573
2017 1,572
2016 1,576
2015 1,573
2014 1,581
2013 1,579
2012 1,579
2011 1,579
2010 1,579
2009 1,617
2008 1,697
2007 1,740
2006 1,772
Takeda Pharmaceutical Quarterly Shares Outstanding
(Millions of Shares)
2020-03-31 3,132
2019-12-31 3,115
2019-09-30 3,124
2019-06-30 3,111
2018-12-31 1,573
2018-06-30 1,564
2017-06-30 1,560
2016-06-30 1,564
2015-06-30 1,570
2015-03-31 1,574
2014-12-31 1,578
2014-09-30 1,572
2014-06-30 1,575
2014-03-31 1,578
2013-12-31 1,581
2013-09-30 1,578
2013-06-30 1,581
2013-03-31 1,580
2012-12-31 1,579
2012-09-30 1,579
2012-06-30 1,579
2012-03-31 1,579
2011-12-31 1,578
2011-09-30 1,582
2011-03-31 1,579
2010-03-31 1,579
2009-09-30 6
2009-03-31 1,588
2008-03-31 1,940
2007-03-31 1,716
2006-03-31 1,790
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $55.173B $30.200B
Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company, engaged in manufacturing, marketing, and importing/exporting pharmaceutical drugs. Takeda's core business comprise of ethical drugs and its portfolio includes lansoprazole for the treatment of peptic ulcers, leuprolide acetate for the treatment of prostate cancer and endometriosis, pioglitazone hydrocholoride for the treatment of diabetes, and candesartan cilexetil for the treatment of hypertension. The Company promotes enhancing R&D pipeline, while concentrating its management resources to the four core therapeutic areas: lifestyle-related diseases, oncology and urological diseases, central nervous system disease and gastroenterological diseases. It operates in two segments- Ethical drug business and Consumer healthcare business. Consumer healthcare business provides Alinamin (vitamin B1 derivative preparations, etc.), Benza (cold remedies). Takeda Pharmaceutical Company Limited is headquartered in Osaka, Japan.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $67.879B 38.52
Astellas Pharma (ALPMY) Japan $30.403B 15.41
UCB SA (UCBJF) Belgium $24.547B 0.00
Eisai (ESALY) Japan $23.444B 20.32
Merck (MKGAF) Germany $16.680B 21.87
Grifols, S.A (GRFS) Spain $13.380B 16.63
Catalent (CTLT) United States $12.966B 50.13
Neurocrine Biosciences (NBIX) United States $12.551B 58.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.340B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 0.00
Ionis Pharmaceuticals (IONS) United States $8.770B 46.63
IPSEN SA ADR (IPSEY) France $7.793B 0.00
Orion OYJ (ORINY) Finland $7.077B 31.71
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.421B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.058B 9.70
United Therapeutics (UTHR) United States $5.331B 10.10
STADA ARZNEIMI (STDAF) Germany $4.916B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $4.903B 535.33
Nektar Therapeutics (NKTR) United States $4.389B 0.00
FibroGen (FGEN) United States $4.054B 0.00
Evotec AG (EVTCY) Germany $4.040B 108.88
Hypermarcas (HYPMY) Brazil $3.708B 13.64
ChemoCentryx (CCXI) United States $3.675B 0.00
PTC Therapeutics (PTCT) United States $3.641B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.572B 10.57
Cronos Group (CRON) Canada $2.449B 70.20
Pacira BioSciences (PCRX) United States $2.421B 49.55
Sage Therapeutics (SAGE) United States $2.349B 0.00
Xencor (XNCR) United States $1.915B 0.00
Corcept Therapeutics (CORT) United States $1.893B 18.77
USANA Health Sciences (USNA) United States $1.824B 18.70
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.658B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.649B 12.62
Zogenix (ZGNX) United States $1.625B 0.00
Akebia Therapeutics (AKBA) United States $1.609B 0.00
Heron Therapeutics (HRTX) United States $1.558B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.488B 16.03
Indivior (INVVY) United States $1.465B 18.18
Karyopharm Therapeutics (KPTI) United States $1.418B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.389B 0.00
Esperion Therapeutics (ESPR) United States $1.354B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.200B 0.00
Translate Bio (TBIO) United States $1.195B 0.00
VAXART, INC (VXRT) United States $1.075B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.061B 47.37
Tilray (TLRY) Canada $0.979B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.922B 0.00
Endo (ENDP) Ireland $0.822B 1.27
ImmunoGen (IMGN) United States $0.804B 0.00
Trillium Therapeutics (TRIL) Canada $0.642B 0.00
Aerie Pharmaceuticals (AERI) United States $0.639B 0.00
Radius Health (RDUS) United States $0.612B 0.00
Collegium Pharmaceutical (COLL) United States $0.596B 0.00
Ardelyx (ARDX) United States $0.588B 0.00
Molecular Templates (MTEM) United States $0.580B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.553B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.525B 12.70
Flexion Therapeutics (FLXN) United States $0.519B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.513B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.507B 0.00
Siga Technologies (SIGA) United States $0.505B 0.00
Innate Pharma SA (IPHYF) France $0.497B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.490B 19.10
Ocular Therapeutix (OCUL) United States $0.447B 0.00
TherapeuticsMD (TXMD) United States $0.446B 0.00
DURECT (DRRX) United States $0.437B 0.00
Altimmune (ALT) United States $0.411B 0.00
Organogenesis Holdings (ORGO) United States $0.407B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.389B 0.00
Harpoon Therapeutics (HARP) United States $0.386B 0.00
Calithera Biosciences (CALA) United States $0.371B 0.00
MEI Pharma (MEIP) United States $0.371B 0.00
Taiwan Liposome (TLC) Taiwan $0.315B 0.00
Concert Pharmaceuticals (CNCE) United States $0.313B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.296B 0.00
IMV INC (IMV) Canada $0.268B 0.00
PROFOUND MEDICL (PROF) Canada $0.262B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.253B 0.00
Redhill Biopharma (RDHL) Israel $0.230B 0.00
KalVista Pharmaceuticals (KALV) United States $0.221B 0.00
Rafael Holdings (RFL) United States $0.219B 0.00
CASI Pharmaceuticals (CASI) United States $0.212B 0.00
OptiNose (OPTN) United States $0.211B 0.00
Lannett Co Inc (LCI) United States $0.207B 4.55
Nature's Sunshine Products (NATR) United States $0.195B 25.69
Jounce Therapeutics (JNCE) United States $0.180B 4.29
Nivalis Therapeutics (ALPN) United States $0.175B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.158B 0.00
Aquestive Therapeutics (AQST) United States $0.147B 0.00
Otonomy (OTIC) United States $0.132B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.125B 0.00
Heat Biologics (HTBX) United States $0.124B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.121B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.120B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.111B 0.00
Champions Oncology (CSBR) United States $0.110B 0.00
MediWound (MDWD) Israel $0.109B 0.00
Xeris Pharmaceuticals (XERS) United States $0.109B 0.00
Recro Pharma (REPH) United States $0.104B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.102B 0.00
CTI BioPharma (CTIC) United States $0.102B 0.00
Onconova Therapeutics (ONTX) United States $0.097B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.097B 0.00
Biomerica (BMRA) United States $0.095B 0.00
Sundial Growers (SNDL) Canada $0.094B 0.00
Hemispherx BioPharma (AIM) United States $0.092B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.087B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.086B 0.00
Aclaris Therapeutics (ACRS) United States $0.085B 0.00
SCYNEXIS (SCYX) United States $0.068B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.068B 0.00
PolarityTE (PTE) United States $0.066B 0.00
Lipocine (LPCN) United States $0.062B 0.00
RENEURON GP (RNUGF) United Kingdom $0.059B 0.00
ElectroCore (ECOR) United States $0.059B 0.00
CV Sciences (CVSI) United States $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.050B 29.91
Addex Therapeutics (ADXN) Switzerland $0.049B 0.00
Natural Alternatives (NAII) United States $0.049B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.048B 0.00
Infinity Pharmaceuticals (INFI) United States $0.048B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.046B 0.00
Novan (NOVN) United States $0.043B 0.00
IsoRay (ISR) United States $0.042B 0.00
Forward Pharma (FWP) Denmark $0.042B 0.00
Mannatechorporated (MTEX) United States $0.041B 7.78
Opiant Pharmaceuticals (OPNT) United States $0.041B 86.73
Jaguar Animal Health (JAGX) United States $0.039B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.037B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.035B 0.00
GTx (ONCT) United States $0.035B 0.00
AgeX Therapeutics (AGE) United States $0.034B 0.00
Neos Therapeutics (NEOS) United States $0.032B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.026B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.024B 0.00
India Globalization Capital (IGC) United States $0.021B 0.00
Flex Pharma (SLRX) United States $0.020B 0.00
Iterum Therapeutics (ITRM) Ireland $0.019B 0.00
Bio-Path Holdings (BPTH) United States $0.019B 0.00
ProPhase Labs (PRPH) United States $0.018B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.018B 0.00
Can-Fite Biopharma (CANF) Israel $0.018B 0.00
Regulus Therapeutics (RGLS) United States $0.016B 0.00
Cyanotech (CYAN) United States $0.014B 32.84
Shineco (TYHT) China $0.014B 0.00
RXi Pharmaceuticals (PHIO) United States $0.013B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.013B 0.00
China SXT Pharmaceuticals (SXTC) China $0.012B 0.00
HANCOCK JAFFE (HJLI) United States $0.009B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.009B 0.00
Midatech Pharma (MTP) United Kingdom $0.009B 0.00
Vical (BBI) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00